Press release
Global Brain Tumor Drugs Market to Reach $5.27 Billion by 2029, Growing at 6.6% CAGR
Brain Tumor Drugs
The surge in the Brain Tumor drugs market growth is largely due to the rising incidence of Neurological Disorders worldwide. Neurological Disorders have become among the most commonplace due to longer lifespan, increased vulnerability to infections, and inactive lifestyles. For instance, the National Brain Tumor Society reports that around 700,000 individuals in the United States currently have a primary brain tumor, and an approximate 86,000 new diagnoses are expected. This upsurge in the patient count with neurological disorders including brain tumors, thus fuels the increasing necessity for brain tumor medicines, propelling the growth of the brain tumor drugs market.
Get Your Brain Tumor Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report
What growth opportunities are expected to drive the brain tumor drugs market's CAGR through 2034?
In recent times, the market size for brain tumor drugs has seen a robust growth. The market value is projected to rise from $3.81 billion in 2024 to $4.09 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.2%. Factors attributing to this growth during the historical period include rising instances of neurological disorders, higher healthcare expenditures, a growing number of approvals for oncology drugs, augmentation in pharmaceutical research and development expenditures, and advancements in cancer drug discovery.
The market for brain tumor drugs is projected to witness significant expansion in the coming years, swelling to $5.27 billion by 2029 with a compound annual growth rate (CAGR) of 6.6%. This expected growth during the forecast period can be ascribed to factors such as a heightened rate of cancer incidence, increased expenditure in healthcare, growth in the elderly population, a robust pipeline of medicines, and updated FDA rules for the advancement of biologics drugs. Key trends anticipated during the forecast period involve investment in drug combinations for the treatment of brain tumors, embracing phase zero clinical trials to boost effectiveness, incorporation of technology to enhance drug delivery and drug efficiency, broadening the scope of cell and gene therapy, and engaging in strategic partnerships and acquisitions.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2588&type=smp
What are the emerging trends shaping the future of the brain tumor drugs market?
Nanotechnology is the focus of corporations in the brain tumor drugs market for treatment advancement. The method of using nanoparticles to transport combined drugs directly to cancer cells or the tumor has been adopted, leading to a decline in drug dosage, enhanced product longevity, and decreased toxic nature. A few nano drugs have demonstrated effectiveness in crossing the blood-brain barrier, previously a substantial obstacle in Brain tumor treatments. For example, Liposomes nanoparticles can deliver drugs directly to cancer cells and can penetrate the blood-brain barrier when coated with transferrin. Corporations such as GE Healthcare, Sigma-Tau Pharmaceuticals Inc., Johnson & Johnson, Merck & Company Inc., Pfizer, Inc., and Celgene Corporation are embracing this technology to enhance existing medicinal methods and treatment options.
Which growth-oriented segments of the brain tumor drugs market are leading the industry's development?
The brain tumor drugs market covered in this report is segmented -
1) By Drugs: Temozolomide, Bevacizumab, Other Drugs
2) By End User: Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other End-Users
Subsegments:
1) By Temozolomide: Oral Formulation, Injectable Formulation
2) By Bevacizumab: Monoclonal Antibody Therapy, Combination Therapy With Chemotherapy
3) By Other Drugs: Carmustine, Lomustine, Etoposide, Irinotecan, Novantrone (Mitoxantrone)
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2588
What regions are leading the charge in the brain tumor drugs market?
North America was the largest region in the brain tumor drugs market in 2024. Middle East is expected to be the fastest-growing region in the global brain tumor drugs market share during the forecast period. The regions covered in the brain tumor drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What companies are at the forefront of innovation in the brain tumor drugs market?
Major companies operating in the brain tumor drugs market include F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Pfizer Inc., Merck & Co. Inc., CordenPharma, Eisai Co., Ltd., Emcure Pharmaceuticals Limited, Y-mAbs Therapeutics, Roche India, Novartis Oncology, Arlak Biotech, Healthkind Labs Pvt. Ltd., SwisscheM Healthcare Pvt.Ltd, Apikos Pharma, Kolaz Biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Astellas Pharma Inc, Otsuka Pharmaceutical Co., Ltd, Daiichi Pharmaceutical and Sankyo, AQVIDA GmbH, Baxter International Inc. (UK), AstraZeneca plc, GlaxoSmithKline plc, Veropharm, Biocad, Bristol-Myers Squibb, Celon Pharma, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, Sandoz AG, Eurofarma Laboratórios S.A., TUTEUR Argentina, The Takeda Pharmaceutical Company Limited, Pierre Fabre Group, Celnova Pharma, Pfizer S.R.L., Teva Pharmaceutical Industries Ltd., BIOPHARMA-MEA, NeoTX, AID Genomics Limited, Julphar, Sanofi, Novo Nordisk A/S, Bayer, Kitov Pharma Limited, CureTech Ltd., Neopharma, Eurolab, Aspen, Adcock Ingram.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2588&type=smp
What Is Covered In The Brain Tumor Drugs Global Market Report?
•Market Size Forecast: Examine the brain tumor drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the brain tumor drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the brain tumor drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the brain tumor drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the brain tumor drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the brain tumor drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the brain tumor drugs market.
•Competitive Landscape: Review strategic developments in the brain tumor drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Brain Tumor Drugs Market to Reach $5.27 Billion by 2029, Growing at 6.6% CAGR here
News-ID: 3898919 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
